Instylla, Inc. is a privately held company based in Bedford, MA, focused on developing novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in interventional oncology and the peripheral vasculature. Instylla was founded in 2017 by Incept LLC and is funded by several leading venture capital groups.